Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease.

Shuko IwataniHideki IijimaYuriko OtakeTakahiro AmanoMizuki TaniTakeo YoshiharaTaku TashiroYoshiki TsujiiTakahiro InoueYoshito HayashiKiyoshi TakedaAkio HayashiSetsuko FujitaShinichiro ShinzakiTetsuo Takehara

Published in: Journal of gastroenterology and hepatology (2020)

The lipid profile in IBD patients exhibits significant alterations, and PS levels are associated with clinical disease activity in CD patients.

Keyphrases

disease activity
mass spectrometry
ejection fraction
newly diagnosed
rheumatoid arthritis
prognostic factors
patients with inflammatory bowel disease
patient reported outcomes
rheumatoid arthritis patients
patient reported
juvenile idiopathic arthritis